MRNAVSNPAC• 12 Months (Normalized)
MRNA vs NPAC (Moderna Inc. vs New Providence Acquisition Corp. III)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
MRNA Performance $143.97
+467.03%
Moderna Inc.
Normalized Baseline0.00%
NPAC Performance $10.48
+3.61%
New Providence Acquisition Corp. III
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
+463.42%
MRNA outperforming by 463.42%
MRNANPAC
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
MRNA NPAC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | MRNA Price | MRNA Gain (%) | NPAC Price | NPAC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $143.97 | +467.03% | $10.48 | +3.61% | +463.42% |
| Sep 10, 2026 | $136.62 | +438.09% | $10.47 | +3.46% | +434.63% |
| Sep 09, 2026 | $135.61 | +434.11% | $10.47 | +3.50% | +430.61% |
| Sep 08, 2026 | $140.33 | +452.70% | $10.47 | +3.50% | +449.20% |
| Sep 04, 2026 | $145.55 | +473.26% | $10.49 | +3.71% | +469.55% |
| Sep 03, 2026 | $148.87 | +486.33% | $10.49 | +3.71% | +482.62% |
| Sep 02, 2026 | $150.81 | +493.97% | $10.48 | +3.61% | +490.36% |
| Sep 01, 2026 | $154.27 | +507.60% | $10.47 | +3.51% | +504.09% |
| Aug 31, 2026 | $140.34 | +452.74% | $10.45 | +3.31% | +449.43% |
| Aug 28, 2026 | $137.99 | +443.48% | $10.44 | +3.21% | +440.27% |
| Aug 27, 2026 | $142.77 | +462.31% | $10.47 | +3.46% | +458.85% |
| Aug 26, 2026 | $149.66 | +489.44% | $10.48 | +3.61% | +485.83% |
| Aug 25, 2026 | $158.83 | +525.56% | $10.47 | +3.47% | +522.09% |
| Aug 24, 2026 | $138.89 | +447.03% | $10.47 | +3.46% | +443.57% |
| Aug 21, 2026 | $145.13 | +471.60% | $10.47 | +3.46% | +468.14% |
Page 1 of 17